Serratia infection: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
YazanDaaboul (talk | contribs) |
||
| Line 32: | Line 32: | ||
== Treatment == | == Treatment == | ||
[[Serratia infection medical therapy|Medical Therapy]] | [[Serratia infection prevention|Prevention]] | [[Serratia infection cost- | [[Serratia infection medical therapy|Medical Therapy]] | [[Serratia infection prevention|Prevention]] | [[Serratia infection cost-effectiveness of therapy|Cost-Effectiveness of therapy]] | [[Serratia infection future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 22:08, 6 February 2016
|
Serratia infection Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Serratia infection On the Web |
|
American Roentgen Ray Society Images of Serratia infection |
This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Serratia.
For patient information about Serratia infection, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: S. marsescens; S. entomophilia; S. ficaria; S. fonticola; S. grimesii; S. liquefaciens; S. odoriferae; S. plymuthica; S. proteamaculans; S. quinivorans; S. rubidaea; S. ureilytica; S. liquefaciens complex; pseudohemoptysis; prodigiosin; red pigment
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Serratia infection from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of therapy | Future or Investigational Therapies